This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Prostate Disease  • Oncology  • Prostate Cancer  • Urology  • Alert me on articles by topic

Treating the Patient, Not the PSA

Howard I. Scher, MD

JAMA. 1999;281:1642-1645.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MEASUREMENT OF THE LEVEL OF PROSTATE-specific antigen (PSA) in the blood has had a profound impact on the management of prostate cancer. Heated debates surround early detection and screening.^1-5 Equally controversial is the use and interpretation of serial changes in PSA values for assessing outcomes and determining prognosis.⁶ For the patient who has undergone a radical prostatectomy, a persistent PSA value is a sign of residual disease, but an undetectable value does not necessarily mean cure. But what if the PSA value had been undetectable and then becomes detectable and continues to increase? A rising PSA value can predate other signs of progression by months or even years.⁷ Misinterpretation of the significance of the change in PSA levels can create havoc for patients who are profoundly concerned with their PSA determinations and for physicians who must address the anxieties and fears of their patients. Unfortunately, documentation . . . [Full Text of this Article]

Author Affiliation: Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY.

RELATED ARTICLE

Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Charles R. Pound, Alan W. Partin, Mario A. Eisenberger, Daniel W. Chan, Jay D. Pearson, and Patrick C. Walsh
JAMA. 1999;281(17):1591-1597.
ABSTRACT | FULL TEXT